RIGL Rigel Pharmaceuticals, Inc.
Healthcare$29.01-0.62%ClosedMarket Cap: $536.7M
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$27.33
Target (Median)
$38.00
Target Range
$2.00 - $42.00
Upside from current price: -5.8%
Rating Distribution
0 Strong Buy3 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-22 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-13 | Citigroup | maintain | Buy | Buy |
| 2025-11-05 | Jefferies | upgrade | Buy | Hold |
| 2025-11-05 | Cantor Fitzgerald | maintain | Neutral | Neutral |
| 2025-10-08 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-08-06 | Cantor Fitzgerald | maintain | Neutral | Neutral |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $4.38 | $329.6M | 3 |
| Sun Dec 31 | $4.76 | $370.5M | 3 |
| Mon Dec 31 | $3.18 | $358.4M | 1 |
| Tue Dec 31 | $3.74 | $387.3M | 1 |